The Valley Desk

NCT00538434 · Interventional trial

Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years

Overall registry status Completed

Phase 2 · Phase 3

Conditions Eosinophilic Esophagitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov